Publication | Open Access

The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate

Peptidomimetic InhibitorsMedicineAntiviral Drug DevelopmentAntiviral TherapyVirologyStructure-based DesignAntiviral DrugViral Structural ProteinPharmacologyAntiviral CompoundLike ProteaseBiomolecular EngineeringDrug Discovery